A New Formulation Line for Insulin Vials

The Danish Pharmaceutical Group Novo Nordisk has chosen Bürkert, the fluid control specialists, to equip its latest production line for the formulation of insulin vials at its site in Chartres (Eure-et-Loir), France. A technical solution supported by Bürkert allows the pharmaceutical leader to simplify their processes and increase productivity.

This plant is dedicated to the production and packaging of insulin products with nearly 20 million Euros invested to increase their capacity and build the latest in vial production facilities. “Our Chartres site is divided into three activities – NNP1 unit assigned to the production of 3 mL cartridges, NNP3 unit reserved for packaging products and the new unit will be NNP2, dedicated to the production of bottles” details Olivier Gilles, Technical Project Manager – On Site Vials Formulation Novo Nordisk Chartres. “The new production line will allow the site in Chartres to be a major focus for the production of insulin vials for the Novo Nordisk Group”.

To build its production line, Novo Nordisk started from scratch.